Clinical Trial Results: A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing inhaled PT007 (ASM_DI) to placebo and Ventolin in adults with asthma; results completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• PT007 (AS MDI) (PT007)
• Placebo MDI
• Ventolin Evohaler (albuterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2026-08-27